Avalo Therapeutics, Inc. Common Stock (AVTX) stock analysis and AI prediction
The company facts of Avalo Therapeutics, Inc. Common Stock, with its price and AI prediction for the next 10 market days in SharePreds.
Keep looking in SharePreds
You have looked at today's stocks on this website. SharePreds shows every stock's likelihood of rising, its chart and how its earlier predictions ended, with alerts on the ones you follow.
See all five apps
About Avalo Therapeutics, Inc. Common Stock
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
- Sector
- Healthcare
- Exchange
- NASDAQ
- Market value
- $390.3 million
- Size
- Small cap
- Employees
- 33
- Headquarters
- WAYNE, PA
- Listed since
- Nov. 13, 2015
- Website
- avalotx.com
More Healthcare stocks
Other small cap stocks
Keep going
AVTX questions
What is the AI prediction for AVTX stock?
Each market day our model rates Avalo Therapeutics, Inc. Common Stock (AVTX) Bullish, Neutral or Bearish for the next 10 market days. Predictions are indicative: they rest on price and volume data, and they can be wrong.
How often is the AVTX prediction updated?
Each market day, Monday to Friday, except market holidays. The date of the prediction is shown beside it.
What do Bullish, Neutral and Bearish mean?
Bullish means the model sees a rise as likely over the next 10 market days, Bearish a fall, and Neutral no clear direction.
Where can I see the exact likelihood for AVTX?
In the SharePreds app for iPhone and Android, with the stock's chart, alerts on it and how its earlier predictions ended.
Where can I see AVTX options?
The AVTX options page opens its calls and puts, with price, volume, implied volatility and the Greeks.